China’s National Medical Products Administration (NMPA) has recently released the ninth batch of rules and knowledge points under its intelligent supervision ‘Two Libraries’ framework. While the exact date of issuance is not publicly specified, the update marks a significant step in standardizing clinical use quality control and data reporting for high-end medical devices—including surgical robots and high-definition endoscopes. This development directly affects manufacturers, exporters, and regulatory service providers operating across China’s medical device value chain, primarily by aligning domestic oversight with internationally recognized conformity assessment expectations.

Event Overview

The NMPA recently issued the ninth batch of its intelligent supervision ‘Two Libraries’—comprising a rule library and a knowledge library. The update explicitly defines clinical quality control indicators and standardized data reporting formats for surgical robots and high-definition endoscopes. The framework demonstrates alignment with ISO 13485:2025 and selected provisions of the U.S.-led Medical Device Single Audit Program (MDSAP), as well as EU regulatory expectations under CE/UKCA pathways. As a result, it serves as a domestically generated verification reference for Chinese manufacturers seeking CE or UKCA certification, potentially shortening overseas registration timelines by approximately 4–6 months.

Industries Affected

Direct trading enterprises—particularly those exporting surgical robots or advanced endoscopic systems—are affected because the ‘Two Libraries’ now provide an authoritative, NMPA-endorsed benchmark for technical documentation and post-market data submission. This reduces ambiguity during foreign regulatory reviews but also raises baseline expectations for evidence generation and traceability, increasing pre-submission preparation effort and internal audit rigor.

Raw material procurement enterprises—especially suppliers of precision components (e.g., optical modules, torque-sensing actuators, biocompatible alloys) used in surgical robots—are indirectly impacted. As OEMs tighten design control and risk management requirements to meet the new ‘Two Libraries’-aligned quality indicators, procurement specifications are becoming more performance- and traceability-driven. Suppliers may face increased demand for certified material test reports, lot-level documentation, and process validation records.

Manufacturing enterprises—including original equipment manufacturers (OEMs) and contract manufacturers—face direct operational implications. Compliance with the updated ‘Two Libraries’ requires adjustments to production quality management systems (QMS), especially in areas such as real-time device usage logging, adverse event linkage protocols, and structured clinical outcome data capture. Manufacturers must now treat clinical data not only as a regulatory deliverable but as an embedded QMS input.

Supply chain service enterprises—including regulatory consulting firms, notified body affiliates, and clinical evaluation support providers—are seeing shifts in client demand. There is growing interest in hybrid services that bridge NMPA-aligned data structuring with CE/UKCA technical file compilation. However, the absence of formal mutual recognition between the ‘Two Libraries’ and EU MDR Annexes means these services remain interpretive—not automatic—bridges.

Key Focus Areas and Recommended Actions

Review and map existing QMS against ‘Two Libraries’ clinical indicators

Manufacturers should conduct a gap analysis between current clinical usage tracking mechanisms (e.g., device log files, service call records, hospital feedback channels) and the newly defined quality control metrics—such as procedural success rate thresholds, intraoperative alert frequency limits, and maintenance-interval adherence benchmarks.

Standardize data export formats for international submissions

Since the ‘Two Libraries’ prescribe specific data fields and structures for device usage reporting, companies preparing for CE or UKCA applications should integrate these templates into their internal data management platforms. Doing so avoids manual reformatting later and strengthens consistency across regional submissions.

Engage early with notified bodies on interpretation alignment

Although the framework references ISO 13485:2025 and select MDSAP clauses, no official endorsement or equivalency statement exists from EU or UK authorities. Firms should proactively consult their notified bodies to confirm whether—and how—‘Two Libraries’-generated evidence will be accepted as supplementary or corroborative material in conformity assessments.

Editorial Perspective / Industry Observation

Observably, the NMPA’s move reflects a broader strategic pivot: from reactive post-market surveillance toward proactive, data-informed lifecycle governance. It does not replace CE/UKCA requirements—but rather introduces a parallel domestic accountability layer that increasingly informs global readiness. Analysis shows this is less about harmonization per se and more about building sovereign capacity to generate auditable, clinically grounded evidence. From an industry perspective, the ‘Two Libraries’ are better understood not as a shortcut to market access, but as a signal that clinical real-world data (RWD) is now a core quality attribute—not just a regulatory add-on.

Conclusion

This update underscores a maturing regulatory posture in China’s medical device sector—one where domestic oversight infrastructure is being deliberately engineered to interface with global expectations. For stakeholders, the implication is not reduced complexity, but redistributed responsibility: compliance is no longer siloed across jurisdictions, but interlinked across data systems, quality processes, and clinical workflows. A rational conclusion is that regulatory agility—not just regulatory compliance—will define competitive advantage going forward.

Source Attribution

Official announcement published by the National Medical Products Administration (NMPA), Ninth Batch of Intelligent Supervision ‘Two Libraries’ Rules and Knowledge Points (date unspecified). Further details available via nmpa.gov.cn. Note: Formal acceptance of ‘Two Libraries’ outputs by EU Notified Bodies or the UK MHRA remains unconfirmed and is subject to ongoing observation.